
Read more: http://www.pakalertpress.com/2012/10/30/italy-and-switzerland-ban-novartis-flu-vaccines/?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+pakalert+%28Pak+Alert+Press%29
Italy and Switzerland Ban Novartis Flu Vaccines
The downside of most vaccines, however, is simply this: they don’t really work. The Lancet published a study involving 13,095 unvaccinated adults, only 2.7 percent of whom developed the flu compared to 1.2 percent of vaccinated adults. The flu vaccine’s efficacy was a humble 1.5 percent.
Meanwhile, even low doses of vitamin D—either through the sun, diet, or supplementation—reduces risk of contracting the flu by 42 percent according to a Japanese study involving 430 children. Vitamin D in moderate amounts has none of the horrible side effects that often occur after vaccination, including but not limited to Type 2 diabetes-linked inflammation, autoimmune disease stimulation, and a deadly nerve disease known as Guillain-Barré Syndrome.
Amid political controversy, the Italian government took the highroad last week by suspending sales of flu vaccines when their quality and safety were called into question.
Novartis AG (NOVN) told Italian and Swiss authorities that their products were safe, although the shots did contain particle buildup. Citing Novartis’ failure to provide adequate information for the safe sale of the shots, however, the Italian Health Ministry has banned the 488,000 doses in question.